Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-s-FASENRA-Approves-for-Treatment-of-Children-Aged-6-to-11-with-Severe-Asthma-by-the-US-F-46425415/?utm_source=whatsapp&utm_medium=social&utm_campaign=share